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Exposure to bisphenol A enhanced lung 
eosinophilia in adult male mice
Miao He1*, Takamichi Ichinose2, Seiichi Yoshida2, Hirohisa Takano3, Masataka Nishikawa4,  
Takayuki Shibamoto5 and Guifan Sun1
Abstract 
Background: Bisphenol A (BPA) is useful in many manufacturing processes and is also found in commonly used con-
sumer products. Previous experimental studies have reported that perinatal exposure to BPA promotes the develop-
ment of allergic lung inflammation in childhood and even into adulthood. In this study, the effects of BPA on allergic 
lung inflammation in adults were investigated in murine lungs.
Methods: CD-1 mice were orally administrated with 1 mg of BPA/mouse four times at one-week intervals with or 
without ovalbumin (OVA). The pathologic changes in the airways, cytological alterations in bronchoalveolar lavage 
fluid (BALF), levels of inflammatory cytokines/chemokines in BALF, and OVA-specific IgE and IgG1 antibodies in serum 
were measured in the treated CD-1 mice. In vitro study using RAW264.7 cells, which are macrophage-like cells derived 
from BALB/c male mice, was conducted. The gene expression of cytokines and chemokines were measured.
Results: BPA enhanced eosinophil recruitment induced by OVA in the alveoli and in the submucosa of the airway, 
which has a goblet cell proliferation in the bronchial epithelium. BPA increased Th2 cytokines-interleukin-13 (IL-13), 
eosinophil-relevant cytokines and chemokines, such as IL-5, and CCL2 induced by OVA, in BALF. BPA induced adjuvant 
effects on OVA-specific IgG1 production. In the in vitro study using RAW264.7 cells, BPA increased the mRNA expres-
sion of IL-1β, IL-6, CCL2 and CCL3 compared with the control and OVA groups.
Conclusions: These results suggest that (1) the exposure of BPA could synergize with an OVA challenge to aggravate 
the severity of lung eosinophilia in adult mice, possibly by promoting a Th2-biased immune response and (2) the 
activation of macrophages and inflammatory cytokines released from these cells by BPA could be participating in this 
phenomenon.
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Background
Rapid industrialization and improvement in living stand-
ards come along with an increase in toxic hazards. Bis-
phenol A (4,4′-(propane-2,2-diyl) diphenol or BPA), 
stable in sediment and detectable in almost all bodies of 
water and food, is an intermediate in the production of 
polycarbonate and epoxy resins [1]. Thus, wildlife and 
human exposure to BPA is inevitable, and is likely to con-
tinue and even to increase.
Allergic asthma is an airway inflammatory disease that 
is characterized by bronchial hyper-responsiveness, air-
way eosinophilia, goblet cell hyperplasia and production 
of allergen specific immunoglobulin (Ig) [2]. The preva-
lence of asthma in developed countries is approximately 
10  % in adults and even higher in children, whereas in 
developing countries, the prevalence is lower but increas-
ing rapidly [3]. Previous studies have reported that 
maternal or fetal exposure to BPA exacerbated allergic 
sensitization and bronchial inflammation and respon-
siveness in a susceptible-animal model of asthma [4, 
5]. Asthma patients are exposed to BPA everyday via 
food, water and air. However, to our knowledge, few 
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experimental studies have documented the aggravating 
effects of BPA on allergic asthma in adults.
In the present study, the effects of the BPA used in 
the inner lining of metal cans on ovalbumin (OVA)-
induced lung eosinophilia were examined in adult mice. 
Pathologic changes in airway, cytological alterations in 
bronchoalveolar lavagefluids (BALF), changes of inflam-
matory cytokines and chemokinesin BALF, and enhance-
ment of IgE and IgG1 in serum were investigated.
Macrophages are innate immune cells that play a criti-
cal role in the early phases of host defense against patho-
gens, coordination of the adaptive immune response, and 
regulation of inflammation and tissue repair. Through 
activation signals by environmental cues and various 
ligands, macrophages may change their polarization 
state, leading to altered immune responses [6]. Mac-
rophages produce a variety of cytokines and mediators 
that are vital for immune and inflammatory responses in 
their response in response to external agents [7]. A pre-
vious study has presented evidence supporting the claim 
that BPA plays a role in the modulation of macrophage 
function through their ability to enhance tumor necrosis 
factor (TNF) and interleukin (IL)-6 expression [8].
In the in vitro study, the gene expression of cytokines 
and chemokines in RAW264.7 cells, which are mac-
rophage-like cells derived from BALB/c male mice, was 
measured in the presence of BPA and/or OVA.
Methods
Animals
Male CD-1 mice (5  weeks of age) were purchased from 
Charles River Japan, Inc. (Kanagawa, Japan). Mice 
were checked for abnormal body weight or sickness for 
1  week, and then 48 mice were used at 6  weeks of age. 
They were fed a commercial diet CE-2 (CLEA Japan, Inc., 
Tokyo) and given water ad libitum./Mice were housed in 
plastic cages lined with soft wood chips. The cages were 
placed in an air conditioned room at 23 °C with 55–70 %/
humidity and a light/dark (12 h/12 h) cycle. CD-1 male 
mice were used because of their moderate responsiveness 
to allergic airway inflammation caused by OVA [9]. The 
study adhered to the US. National Institutes of Health 
Guidelines for the use of experimental animals. The ani-
mal care method was approved by the Animal Care and 
Use Committee at Oita University of Nursing and Health 
Sciences in Oita, Japan.
Study protocol
A total of 48 male CD-1 mice were divided into four 
groups (n =  12 per group) according to treatment pro-
tocol: control, BPA, OVA and OVA + BPA. BPA (Sigma-
Aldrich, St Louis, MO) was dissolved in ethanol (Otsuka 
Co, Kyoto, Japan), and then diluted in olive oil (final 
ethanol concentration 5  %) for oral administration. The 
instillation dose of BPA was 1  mg per mouse. The dose 
of BPA used in this study was designed to be an order of 
magnitude lower than the established maximum nonle-
thal threshold in rodents (200  mg/kg BW/d) [10]. Mice 
were orally administrated with 1 mg BPA/0.2 ml olive oil 
or 0.2 ml olive oil (final ethanol concentration 5 %) four 
times at one-week intervals (Fig. 1).
OVA (A7641: Grade VII) was purchased from Sigma-
Aldrich (St. Louis, MO). OVA was dissolved in sterile 
saline (0.9  % NaCl, LPS free) for injection (Otsuka Co, 
Kyoto, Japan); in accordance with previous reports [9, 
11, 12], the instillation dose was 1  μg per mouse. Four 
instillations, with or without OVA, were administered 
at one-week intervals (Fig.  1). Mice were anesthetized 
with 4  % halothane (Takeda Chemical, Osaka, Japan) 
and intratracheally instilled with OVA or sterile saline 
(Otsuka Co., Kyoto, Japan) through a polyethylene tube 
under anesthesia with 4 % halothane (Takeda Chemical, 
Osaka, Japan). One day after the last administration, mice 
from all groups (age  =  9.5  weeks) were euthanized by 
exsanguination under deep anesthesia by intraperitoneal 
injection of pentobarbital (Fig.  1). Total duration of the 
experiment is 3 weeks and a half.
Pathological evaluation
Six of the 12 mice from each group were used for patho-
logic examination. Lungs were fixed in 10 % neutral phos-
phate-buffered formalin. After separation of the lobes, 
2  mm thick blocks were taken for paraffin embedding. 
Embedded blocks were sectioned at a thickness of 3 μm, 
and were stained with hematoxylin and eosin (H and E) 
to evaluate the degree of infiltration of eosinophils or 
lymphocytes in the airway from proximal to distal. Sec-
tions were also stained with periodic acid-Schiff (PAS) to 
evaluate the degree of proliferation of goblet cells in the 
bronchial epithelium. Pathological analysis of the inflam-
matory cells and epithelial cells in the airway of each lung 
lobe on the slides was performed using a Nikon ECLIPSE 
light microscope (Nikon Co, Tokyo, Japan).
Bronchoalveolar lavage fluid (BALF)
The remaining six mice were used to examine the free 
cell contents from BALF. BALF and cell counts were 
conducted by a previously reported method [9, 11, 12]. 
In brief, tracheas were cannulated after the collection 
of blood. The lungs were lavaged with two injections of 
0.8 ml of sterile saline at 37 °C by a syringe. The lavaged 
fluid was harvested by gentle aspiration. The mean vol-
ume retrieved was 90 % of the amount instilled (1.6 ml). 
Fluids from the two lavages were pooled, cooled to 4 °C, 
and centrifuged at 1500 rpm for 10 min. The total amount 
of lavages collected from individual mice was used to 
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measure the protein levels of cytokines and chemokines 
in the BALF. The total cell count of fresh fluid specimen 
was determined using a hemocytometer. Differential cell 
counts were assessed on cytologic preparations. Slides 
were prepared by Cytospin (Sakura Co, Ltd., Tokyo, 
Japan) and stained with Diff-Quik (International Rea-
gents Co, Kobe, Japan). A total of 300 cells were counted 
under oil immersion microscopy. The BALF supernatants 
were stored at −80 °C until analyzed for cytokines.
Quantitation of cytokines in BALF
The cytokine protein levels in the BALF were determined 
using enzyme-linked immunosorbent assays (ELISA). 
IL-1β, IL-6, IL-13, keratinocyte chemoattractant (KC 
or CXCL1), monocyte chemotactic protein-1 (MCP-1 
or CCL2) and macrophage inflammatory protein-1α 
(MIP-1α or CCL3) were measured using ELISA kits from 
R and D Systems Inc. (Minneapolis, MN). IL-5 was meas-
ured using ELISA kits from Endogen (Cambridge, MA).
Antigen‑specific IgE and IgG1 antibodies
OVA-specific IgE and IgG1 antibodies were meas-
ured using a Mouse OVA-IgE ELISA kit and a Mouse 
OVA-IgG1 ELISA kit (Shibayagi Co, Shibukawa, Japan). 
According to the manufacturer’s protocol, 1 U of anti-
OVA IgE is defined as 1.3  ng of antibody, and 1 U of 
anti-OVA IgG1 as 160 ng of antibody. The absorption at 
450 nm (sub-wave length, 620 nm) for OVA-specific IgE 
and IgG1 antibodies was measured using a microplate 
reader (Spectrafluor, Tecan, Salzburg, Austria).
Cell culture
RAW264.7 cells, which are macrophage-like cells derived 
from BALB/c male mice, were cultured at 37  °C in a 
humidified atmosphere of 5 % CO2–95 % air and main-
tained in Dulbecco’s modified Eagle’s medium with 10 % 
heat inactivated fetal bovine serum. For gene expres-
sion analysis, the cells were plated at a concentration of 
4 ×  105 cells per 60-mm dish, and then PBS, OVA and 
OVA +  BPA were added to cells to give BPA final con-
centrations of 0.5 and 5  μg/ml, respectively. Cells were 
then incubated for 12 h.
Gene expression analysis
Total RNA was extracted by standard procedures using 
0.5  ml of Isogen (Nippon Gene) per dish. After DNase 
treatment of the total RNA, cDNA was synthesized by 
reverse transcription using Moloney murine leukemia 
virus (M-MLV). Quantitative polymerase chain reac-
tions (PCR) were performed using an ABI Prism 7000 
Sequence Detection System (ABI) under the same condi-
tions as in previous studies [11, 13]. Two wells were used 
for each sample. The relative expression of each sample 
was calculated as the mean value divided by the mean 
value for GAPDH. The primers and probes used in this 
in vitro study are shown in Table 1.
Statistical analysis
Statistical analyses of cell numbers and cytokine proteins 
in BALF, IgE and IgG1 in serum and of gene expression 
in RAW264.7 cells were conducted using the Tukey Test 
1 2 3 weeks0
(1) Control
(2) BPA
(3) OVA
(4) OVA+BPA
Saline (intratracheal)
Olive oil (i.g.) BPA (i.g.)
OVA (intratracheal)
mice were euthanized
one day after the last treatment 
Fig. 1 Experimental protocol. 1 Control: orally administrated with 0.2 mL olive oil and instilled intratracheally with 0.1 mL of normal saline per 
mouse four times at one-week intervals; 2 BPA: orally administrated with 1 mg/0.2 mL BPA and instilled intratracheally with 0.1 mL of normal saline 
per mouse four times at one-week intervals; 3 OVA: orally administrated with 0.2 mL olive oil and instilled intratracheally with 1 μg/0.1 mL OVA per 
mouse four times at one-week intervals; 4 OVA + BPA: orally administrated with 1 mg/0.2 mL BPA and instilled intratracheally with 1 μg/0.1 mL OVA 
per mouse four times at one-week intervals
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for Pairwise Comparisons (KyPlot Ver.5, Kyens Lab Inc., 
Tokyo, Japan). The Tukey test is essentially a t test, except 
that it corrects for experimental error rate (when there 
are multiple comparisons being made, the probability of 
making a type I error increases—the Tukey test corrects 
for that, and is thus more suitable for multiple compar-
isons than doing a number of t tests would be). Differ-
ences among groups were statistically significant when 
p < 0.05.
Results
BPA increased BALF cell numbers
To evaluate the effect of BPA on lung inflammation 
induced by OVA, the cellular profile of BALF 24 h after 
the last intratracheal instillation was investigated (Fig. 2). 
BPA and OVA alone caused no significant increase in 
the number of macrophages, neutrophils, eosinophils or 
lymphocytes compared with the controls. However, the 
administration of OVA combined with BPA resulted in 
a remarkable increase in the number of macrophages, 
neutrophils, eosinophils and lymphocytes compared with 
controls, BPA and OVA alone (p < 0.05).
BPA enhanced pathologic changes in the airway
To confirm the effects of BPA on airway inflammation 
and goblet cell proliferation caused by OVA, the lung 
pathology of the mice was examined (Fig. 3). No patho-
logic alterations were found in the lungs of the control 
group (Fig.  3a, d). Treatment with OVA alone caused 
slight goblet cell proliferation (Fig.  3b) in the bronchial 
Table 1 Primers and probes used in this in vitro study
Primers and probes Gene sequence
GAPDH sense TGCACCACCAACTGCTTAG
GAPDH antisense GGATGCAGGGATGATGTTC
GAPDH probe CAGAAGACTGTGGATGGCCCCTC
IL-1β sense TCCTGAACTCAACTGTGAAATGC
IL-1β antisense AGCCCAGGTCAAAGGTTTGG
IL-1β probe AGCAGCCCTTCATCTTTTGGGGTCCG
IL-6 sense CCGGAGAGGAGACTTCACAGA
IL-6 antisense GTTGTTCATACAATCAGAATTGCCATT
IL-6 probe ACCACTCCCAACAGACCTGTCTATACCACT
CCL2 sense TCTGGGCCTGCTGTTCACA
CCL2 antisense CCAGCCTACTCATTGGGATCA
CCL2 probe TTGGCTCAGCCAGATGCAGTTAACGC
CCL3 sense ATTCCACGCCAATTCATCGT
CCL3 antisense TTGGAGTCAGCGCAGATCTG
CCL3 probe CCTTTGCTCCCAGCCAGGTGTCATT
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Fig. 2 Cellular profile in bronchoalveolar lavage fluids (BALF). All values were expressed as mean ± SEM. *p < 0.05 vs. Control, †p < 0.05 vs. BPA, 
‡p < 0.05 vs. OVA
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epithelium. The combined instillation of OVA and BPA 
significantly increased goblet cell proliferation in the air-
way and caused prominent infiltration of eosinophils and 
lymphocytes to appear in the connective tissues of the 
airways (Fig. 3c, f ).
BPA enhanced cytokine and chemokine levels in BALF
To investigate the effects of BPA on OVA-induced 
lung eosinophilia, the protein levels of cytokines and 
chemokines in BALF were measured (Fig. 4). OVA + BPA 
increased CXCL1 compared with the control group 
(p < 0.05). OVA + BPA significantly increased IL-1β, IL-6 
and CCL2 compared with the controls, the BPA and the 
OVA groups (p  <  0.05). Furthermore, OVA +  BPA sig-
nificantly increased eosinophil-produced IL-5 and Th-2 
relevant cytokine IL-13 compared with the other groups 
(p < 0.05).
BPA enhanced serum OVA‑specific IgE and IgG1
To examine whether BPA had adjuvant activity on antigen 
specific Ig production, OVA-specific IgE and IgG1 anti-
bodies were measured (Fig.  5). Co-treatment with OVA 
and BPA significantly increased OVA-specific IgE and 
IgG1 production compared with OVA group (p < 0.05).
Cytokine secretion from RAW264.7 cells by BPA
To evaluate secretion of pro-inflammatory cytokines 
from RAW264.7 cells associated with BPA treatment, the 
mRNA expression levels of IL-1β, IL-6, CCL2 and CCL3 
were measured (Fig.  6). BPA significantly increased the 
expressions of IL-1β, IL-6 and CCL3 compared with PBS 
and OVA treatments (p  <  0.05). Furthermore, expres-
sion of IL-1β in OVA  +  BPA5 was higher than that of 
OVA + BPA0.5 (p < 0.05).
Discussion
Although in recent years several experimental studies 
have addressed the question, of whether BPA may affect 
the development and the outcome of allergic diseases, the 
overall picture has still not become clearer. Some stud-
ies demonstrated a BPA-induced increase of Th2-driven 
immune reactions with increased IgE and IL-4 cytokine 
levels, and showed an augmentation of Th1-mediated 
responses with rather decreased IgE levels [14]. In other 
studies, maternal BPA exposure came into focus, since it 
has been suggested that the prenatal period represents 
a critical window for the developing immune system to 
be primed towards a specific immune phenotype [15]. 
However, the data concerning prenatal BPA exposure 
Fig. 3 Effects of BPA on pathological changes in the lungs. a and d No pathological changes in lungs treated with saline. b Slight proliferation of 
goblet cells that have mucus stained pink with PAS solution in the airway epithelium treated with OVA alone. c Marked proliferation of goblet cells 
and numerous inflammatory cells in the airway treated with OVA + BPA. e Slight infiltration of eosinophils and lymphocytes into the airway submu-
cosa treated with OVA alone. f Marked infiltration of eosinophils and lymphocytes into connective tissue in the airway treated with OVA + BPA. a–c 
PAS stain; c–e HE stain; ×200
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Fig. 4 Cytokines and chemokines expression in bronchoalveolar lavage fluids (BALF). All values were expressed as mean ± SEM. *p < 0.05 vs. Con-
trol, †p < 0.05 vs. BPA, ‡p < 0.05 vs. OVA
0
5
10
15
20
25
Control BPA OVA OVA+BPA
0
2000
4000
6000
8000
10000
12000
14000
Control BPA OVA OVA+BPA
O
VA
-s
pe
ci
fic
 Ig
E
(m
U
/m
L)
O
VA
-s
pe
ci
fic
 Ig
G
1 
(m
U
/m
L)
*†‡
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are diverse, ranging from increased asthma susceptibil-
ity [4] to an elevated Th1 immune response [14] or to no 
effects [16]. These striking differences might be caused 
primarily by the BPA doses used in the various studies, 
which ranges from 0.5 to 5000 mg/kg/day, or by diverse 
exposure routes, resulting in different bioavailability and 
metabolism of BPA [17]. In the present study, the immu-
notoxicity of BPA in adult male mice were investigated.
The results of this study suggest that co-exposure to 
BPA and OVA caused increases in neutrophil and eosino-
phil accumulation in BALF, and eosinophil infiltration 
and proliferation of goblet cells in the airway, which are 
effects pathologically similar to human asthma. There 
were also remarkable increases in the expression of pro-
inflammatory cytokines (IL-1β, IL-5, IL-6 and IL-13), and 
chemokines (KC and MPC-1) in BALF, suggesting that 
co-exposure may cause increased neutrophil and eosino-
phil accumulation via the remarkable increases of these 
pro-inflammatory mediators.
The Th2 cytokine IL-5 stimulates the differentiation 
of bone marrow cells to form eosinophils, which are 
then activated and induced by eotaxins to migrate into 
inflammatory tissue [18]. IL-13, also released from Th2 
lymphocytes, stimulates B cells, induces the production 
of antigen specific antibodies [19, 20], and promotes 
mucous secretion and the production of mucous cells, 
such as goblet cells, in the bronchial epithelium [21]. Our 
study indicates that the co-treatment of OVA and BPA 
significantly elevated the expression of IL-5 and IL-13 
compared with either OVA alone or BPA alone. These 
Th2-derived cytokines are key mediators in the symp-
toms of asthma and are critical for the recruitment and 
survival of eosinophils [22], the production of antigen 
specific antibodies [20], and the production of mucous 
cells, such as goblet cells, in the bronchial epithelium 
[21]. In this study, a significant correlation was observed 
between IL-5 and eosinophils (Fig.  5a) and between 
IL-13 and eosinophils (Fig.  5b) in BALF. Therefore, the 
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Fig. 6 mRNA expression in RAW264.7 mouse macrophage cells. All values were expressed as mean ± SEM. *p < 0.05 vs. Control, †p < 0.05 vs. OVA, 
‡p < 0.05 vs. OVA + BPA0.5
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occurrence of airway injury during co-treatment may be 
due to activated eosinophils via Th2-associated effector 
molecules.
Eosinophils are proinflammatory granulocytes impli-
cated in host immunity to parasitic infections and aller-
gic diseases such as asthma, allergic rhinitis and atopic 
dermatitis [23]. Appropriate stimuli such as immuno-
globulins [24], cytokines [25] and lipid mediators, includ-
ing leukotrienes [26] and platelet-activating factors [27], 
induce degranulation of toxic eosinophil granule pro-
teins. Subsequent tissue damage induced by eosinophil 
granule proteins and superoxides contributes to the air-
way inflammation associated with such diseases [23, 28].
When we investigated OVA-specific immunoglobu-
lin production, we detected adjuvant effects of BPA on 
IgG1 production. IgG1 can contribute to antigen-spe-
cific eosinophil degradation via FcγRII on the surface 
of eosinophils [29]. Therefore, increased levels of OVA-
specific IgG1 might be related to the heightened levels of 
cytokines and lung eosinophilia.
Macrophages are key cells in innate immune responses 
in the lung: they are among the most abundant cells and 
one of the first to encounter allergens and other threats 
to homeostasis [30]. Depending on the signals received, 
macrophages can be pro- or anti-inflammatory, immu-
nogenic or tolerogenic, and can destroy or repair tissue 
[31]. Our present results show that administration of 
BPA induced proinflammatory cytokine and chemokine 
levels. These results provided further confirmation that 
BPA exacerbates inflammation and airway symptoms in 
asthmatic mice.
Conclusions
In conclusion, in this novel study on adult murine asthma 
model, we showed an aggravating effect of BPA on eosin-
ophil infiltration and airway inflammation by increas-
ing levels of Th2 cytokines and chemokines. In addition, 
BPA had an enhancing effect on the more activated mac-
rophages, as it increased proteins expression associated 
with inflammation by these cells. This study confirms 
that BPA exerts potential effects on allergic inflamma-
tion in allergic asthmatics vs. healthy mice and supports 
findings of previous epidemiologic studies on popula-
tions, which indicate BPA can exacerbate allergic airways 
inflammation. The experimental findings in the present 
study may serve as a warning about the ill effects of high 
doses of BPA on the adult human respiratory system.
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